MarketPeel
Insider Trading Intelligence
EVP R&D, Chief Medical Officer
Thu, Feb 22, 2024
Feb 22
exercised or converted securities in ALKS
12,278 shares @ $0.00
Decreased holdings by -50.00%
Net across this filing: +6.90% (+6,826 shares)
ALKSAlkermes plc.
Health CarePharmaceuticals
1D0.00%
1W-1.49%
1M-8.62%
3M
6M
1Y

Recent insider activity at ALKS

FREE · DAILY · 6 AM ET

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback